[Tumor lysis syndrome].

Name: [Tumor lysis syndrome].
Creator: Kiyohiko, Hatake
Keywords: Risk Factors, Humans, Antineoplastic Agents, Tumor Lysis Syndrome, 3. Good health

Kiyohiko, Hatake

Found an issue? Give us feedback

https://pubmed.ncbi....arrow_drop_down

https://pubmed.ncbi.nlm.nih.go...

Article . 2009

Data sources: Europe PubMed Central

[Tumor lysis syndrome].

descriptionPublicationkeyboard_double_arrow_right Article 09 Jan 2009 Japanese Journal:Gan to kagaku ryoho. Cancer & chemotherapy, volume 35 (issn: 0385-0684,

Copyright policy )

Authors: Kiyohiko, Hatake;

pmid: 19098401

[Tumor lysis syndrome].

- Summary
- Subjects
- Metrics

Abstract

Recently, the ASCO guideline has added TLS. Prevention and recognition of the disease and state are important. Molecular targeting drugs, small molecule tyrosine kinase inhibitors and monoclonal antibodies induced rapid regression of the tumors and carry a risk of TLS. The recognition of the disease which may have a high risk of TLS and laboratory TLS is important.

Keywords

Risk Factors, Humans, Antineoplastic Agents, Tumor Lysis Syndrome

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average